Benitec Biopharma Inc.
BNTC | NASDAQ
$11.10
+$0.22 (+2.02%)
Sep 22, 2026, 10:09 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -13.65 | -11.14 | -2.71 | -0.29 | -1.02 | -2.65 |
PEG Ratio | 2.05 | 0.18 | 0.03 | 0.01 | 0.03 | 0.04 |
PS Ratio | n/a | n/a | n/a | 75.02 | 519.41 | 1.24K |
PB Ratio | 3.52 | 4.35 | 1.58 | 27.85 | 13.16 | 3.65 |
P/FCF Ratio | -37.48 | -17.95 | -3.80 | -0.31 | -2.38 | -5.59 |
P/OCF Ratio | -37.71 | -17.96 | -3.84 | -0.31 | -2.38 | -5.69 |
OCF/S Ratio | n/a | n/a | n/a | -24.02K | -21.78K | -21.75K |
Debt / Equity Ratio | 0 | 0.01 | 0.01 | 2.77 | 0.28 | 0.01 |
Quick Ratio | 34 | 54.67 | 10.49 | 0.94 | 1.90 | 15.05 |
Current Ratio | 34 | 54.67 | 10.49 | 0.94 | 1.90 | 15.05 |
Asset Turnover | n/a | n/a | n/a | 0.02 | 0.01 | 0 |
Interest Coverage | n/a | 12.71 | n/a | -578.21 | -557.94 | -2.27K |
Return on Equity | -25.73% | -38.97% | -46.04% | -9.68K% | -631.78% | -69.38% |
Return on Assets | -24.94% | -38.07% | -41.66% | -438.22% | -304.84% | -64.93% |
Return on Invested Capital | -28.80% | -42.55% | -47.28% | -2.51K% | -483.46% | -67.23% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 100% | 87.67% | -108.47% |
Net Profit Margin | n/a | n/a | n/a | -26.08K% | -24.94K% | -23.53K% |
Pretax Profit Margin | n/a | n/a | n/a | -26.08K% | -24.94K% | -23.53K% |
Operating Profit Margin | n/a | n/a | n/a | -25.44K% | -24.46K% | -23.04K% |
FCF Margin | n/a | n/a | n/a | -24.02K% | -21.8K% | -22.12K% |
EBITDA Margin | n/a | n/a | n/a | -24.93K% | -24.36K% | -22.8K% |
Add to Watchlist
Select watchlists to add or remove BNTC